Paper41378286
Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors.
El-Marouk K and 11 others. Front Oncol, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors. Papers, record 41378286. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41378286
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Long-term outcomes and patterns of failure after empiric SBRT for presumed early-stage lung tumors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29863955 | Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29863955 | PubMed |
| 2 | 19097774 | New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). | Eur J Cancer | 2009 | https://conductscience.org/library/papers/19097774 | PubMed |
| 3 | 28461257 | The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer. | J Thorac Oncol | 2017 | https://conductscience.org/library/papers/28461257 | PubMed |
| 4 | 17570609 | Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy. | Int J Radiat Oncol Biol Phys | 2007 | https://conductscience.org/library/papers/17570609 | PubMed |
| 5 | 30943123 | Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial. | J Clin Oncol | 2019 | https://conductscience.org/library/papers/30943123 | PubMed |
| 6 | 24334338 | Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. | Ther Adv Respir Dis | 2014 | https://conductscience.org/library/papers/24334338 | PubMed |
| 7 | 30225431 | Stereotactic Body Radiotherapy for Medically Inoperable Stage I-II Non-Small Cell Lung Cancer: The Mayo Clinic Experience. | Mayo Clin Proc Innov Qual Outcomes | 2018 | https://conductscience.org/library/papers/30225431 | PubMed |
| 8 | 39877030 | Next-Generation Sequencing Analysis on Image-Guided Biopsy Samples in Early-Stage Lung Cancer: Feasibility Study and Comparison With Surgical Samples. | JTO Clin Res Rep | 2025 | https://conductscience.org/library/papers/39877030 | PubMed |
| 9 | 27987578 | Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. | Lung Cancer | 2016 | https://conductscience.org/library/papers/27987578 | PubMed |
| 10 | 29658856 | Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer. | N Engl J Med | 2018 | https://conductscience.org/library/papers/29658856 | PubMed |
| 11 | 21079145 | The evolving role of histology in the management of advanced non-small-cell lung cancer. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/21079145 | PubMed |
| 12 | 40760181 | Empiric stereotactic body radiotherapy for presumed early-stage lung cancer : Pulmonary function changes, treatment-related toxicity and survival outcome. | Strahlenther Onkol | 2026 | https://conductscience.org/library/papers/40760181 | PubMed |
| 13 | 25981812 | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25981812 | PubMed |
| 14 | 23649456 | Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. | Chest | 2013 | https://conductscience.org/library/papers/23649456 | PubMed |
| 15 | 19414667 | Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. | J Clin Oncol | 2009 | https://conductscience.org/library/papers/19414667 | PubMed |
| 16 | 32004581 | To Biopsy or Not to Biopsy?: A Matched Cohort Analysis of Early-Stage Lung Cancer Treated with Stereotactic Radiation with or Without Histologic Confirmation. | Int J Radiat Oncol Biol Phys | 2020 | https://conductscience.org/library/papers/32004581 | PubMed |
| 17 | 35108059 | Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer. | J Clin Oncol | 2022 | https://conductscience.org/library/papers/35108059 | PubMed |
| 18 | 36890550 | Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof. | Radiat Oncol | 2023 | https://conductscience.org/library/papers/36890550 | PubMed |
| 19 | 9129544 | The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. | Arch Intern Med | 1997 | https://conductscience.org/library/papers/9129544 | PubMed |
| 20 | 23287852 | Patterns of failure after stereotactic body radiation therapy or lobar resection for clinical stage I non-small-cell lung cancer. | J Thorac Oncol | 2013 | https://conductscience.org/library/papers/23287852 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41378286
GET https://conductscience.org/api/papers/v1/41378286/references?page=2